Full Paper
2ꢂH-18 and 2ꢂH-15), 3.68 (t, J=5.8 Hz, 1H; H-1), 3.26–3.17 (m,
3H; 2ꢂH-16 and H-3a), 2.93 (ddd, J=13.4, 5.2, 3.4 Hz, 1H; H-3b),
2.86–2.75 (m, 1H; H-4a), 2.59–2.44 (m, 3H; H-4b and 2ꢂH-12),
1.88–1.70 ppm (m, 4H; 2ꢂH-10 and 2ꢂH-11); 13C NMR (75 MHz,
CDCl3): d=208.9 (Cq, C14), 137.0 (CH, C17), 136.6 (Cq, CAr), 136.0 (Cq,
CAr), 135.5 (Cq, CAr), 128.7 (CH, 2ꢂCAr), 127.5 (Cq, CAr), 126.9 (CH, CAr),
126.3 (CH, 2ꢂCAr), 121.6 (CH, CAr), 119.5 (CH, CAr), 118.2 (CH, CAr),
117.4 (CH2, C18), 110.8 (CH, CAr), 108.2 (Cq, CAr), 105.0 (Cq, C13), 78.3
(CH2, C15), 56.5 (CH2, C16), 56.2 (CH, C1), 45.3 (CH2, C3), 34.0 (CH2,
C10), 29.8 (CH2, C12), 24.8 (CH2, C11), 18.2 ppm (CH2, C4); HRMS
(ESI): m/z calcd for C26H29N2 369.2335 [M+H]+; found 369.2331.
CAr), 127.2 (CH, C4), 127.2 (Cq, CAr), 126.2 (CH, 2ꢂCAr), 121.9 (CH,
CAr), 119.8 (CH, CAr), 118.6 (CH, CAr), 111.1 (CH, CAr), 108.8 (Cq, CAr),
61.7 (CH, C13b), 52.9 (CH2, C5), 51.0 (CH2, C7), 31.2 (CH2, C1), 30.5
(CH2, C2), 21.0 ppm (CH2, C8); HRMS (ESI): m/z calcd for C22H23N2
315.1861 [M+H]+; found 315.1875.
Synthesis of (4R,12bS)-4-phenethyl-1,2,3,4,6,7,12,12b-octahy-
droindolo[2,3-a]quinolizine (19): Tetrahydro-b-carboline 2t
(120 mg, 0.326 mmol, two diastereoisomers), Pd(PPh3)4 (18.7 mg,
0.016 mmol), and 1,3-dimethylbarbituric acid 11 (152 mg,
0.978 mmol) were introduced in a reaction flask that was purged
with argon and dissolved in CH2Cl2 (12 mL). The reaction mixture
was stirred at RT for 16 h. A saturated aqueous solution of NaHCO3
was added, the organic layer was separated, and the aqueous
phase was extracted twice with CH2Cl2. Combined organic layers
were dried with MgSO4, filtered, and concentrated under vacuum.
The crude mixture was then purified by flash chromatography
(EtOAc/heptane, 20:80 to 100% EtOAc) to give a mixture of 18a
and 18b (65 mg, 0.199 mmol, 61%) and 18c (11.7 mg, 0.036 mmol,
11%). The mixture of 18a and 18b (35 mg, 0.107 mmol) was intro-
duced in a reaction flask that was purged with argon and dissolved
in THF/H2O (8 mL, 3:1). RuCl3·3H2O (3.6 mg, 0.006 mmol) and
NaBH4 (11.5 mg, 0.305 mmol) were then added and the mixture
was stirred at 508C for 16 h. Upon completion of the reaction, the
mixture was cooled to RT and a saturated aqueous solution of
NaHCO3 was added. The organic layer was separated, the aqueous
phase was extracted twice with MTBE, and the combined organic
layers were dried with MgSO4, filtered, and concentrated under
vacuum. The crude mixture was then purified by flash chromatog-
raphy (EtOAc/heptane, 20:80 to 40:60) to afford cis-19. Yield:
24 mg (0.073 mmol, 69%); orange oil; Rf =0.25 (heptane/EtOAc,
65:35); [a]2D5 =ꢀ25.9 (c 1.00, CHCl3); IR (neat): n˜ =3409, 2928, 2854,
1574, 1509, 1465, 1301, 1259, 1216, 1158, 1059, 1036, 870, 820,
General procedure for the tandem Pd0-catalyzed deprotection/
cyclization: Tetrahydro-b-carboline
2
(1 equiv), Pd(PPh3)4
(0.05 equiv), and 1,3-dimethylbarbituric acid 11 (3 equiv) were in-
troduced in a reaction flask that was purged with argon. CH2Cl2
was then added and the mixture was stirred at 408C or RT for 6 h.
Upon completion of the reaction, the mixture was cooled to RT
and a saturated aqueous solution of NaHCO3 was added. The or-
ganic layer was separated and the aqueous phase was extracted
twice with CH2Cl2. The combined organic layers were dried with
MgSO4, filtered, and concentrated under vacuum. The crude mix-
ture was then purified by flash chromatography to give the desired
products 12, 16, 17, or 18.
Typical
procedure
for
(4S,12bS)-4-phenyl-4-vinyl-
1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizine (12i): Pre-
pared according to the general procedure using 2l (75 mg,
0.203 mmol), Pd(PPh3)4 (11.7 mg, 0.010 mmol), and DMBA 11
(95 mg, 0.609 mmol) in CH2Cl2 (7.5 mL). Purification on silica gel
(EtOAc/petroleum ether, 2.5:97.5) afforded 12i. Yield: 44 mg
(0.134 mmol, 66%); yellow oil; Rf =0.27 (EtOAc/petroleum ether,
2.5:97.5); [a]2D5 =ꢀ48.2 (c 1.00, CHCl3); IR (neat): n˜ =3421, 2057,
2928, 2845, 1597, 1446, 1379, 1301, 1215, 1109, 1032, 1005, 923,
737, 663 cmꢀ1 1H NMR (500 MHz, CD3CN): d=8.90 (s, 1H; H-12),
;
1
739, 703 cmꢀ1; H NMR (500 MHz, CDCl3): d=7.69 (s, 1H; ArH), 7.65
7.41 (d, J=7.6 Hz, 1H; ArH), 7.33–7.25 (m, 5H; 5ꢂArH), 7.20–7.16
(m, 1H; ArH), 7.06 (t, J=7.3 Hz, 1H; ArH), 7.00 (t, J=7.6 Hz, 1H;
ArH), 3.47 (dt, J=11.6, 3.7 Hz, 1H), 3.42 (d, J=9.5 Hz, 1H), 2.82–
2.64 (m, 4H), 2.49–2.44 (m, 1H), 2.38–2.33 (m, 1H), 2.10–2.06 (m,
1H), 1.92–1.88 (m, 2H), 1.72–1.69 (m, 1H), 1.56–1.48 ppm (m, 3H);
13C NMR (75 MHz, CDCl3): d=142.9 (Cq, CAr), 141.4 (Cq, CAr), 136.3
(Cq, CAr), 128.6 (CH, 2ꢂCAr), 128.5 (CH, 2ꢂCAr), 127.6 (Cq, CAr), 126.0
(CH, CAr), 121.5 (CH, CAr), 119.5 (CH, CAr), 118.3 (CH, CAr), 110.9 (CH,
CAr), 108.4 (Cq, CAr), 61.4 (CH, C4), 60.3 (CH, C12b), 45.6 (CH2, C6),
36.1 (CH2, C13), 31.6 (CH2, C14), 30.4 (CH2, C1), 29.6 (CH2, C3), 24.5
(CH2, C2), 22.3 ppm (CH2, C7); HRMS (ESI): m/z calcd for C23H27N2
331.2174 [M+H]+; found 331.2199.
(s, 1H; H-12), 7.45 (d, J=7.6 Hz, 1H; ArH), 7.33–7.28 (m, 2H; 2ꢂ
ArH), 7.24–7.20 (m, 1H; ArH), 7.11 (t, J=7.6 Hz, 1H; ArH), 7.06 (t,
J=7.7 Hz, 1H; ArH), 6.14 (dd, J=18.0, 11.4 Hz, 1H; H-13), 5.68 (dd,
J=11.2, 1.3 Hz, 1H; H-14a), 5.36 (dd, J=18.0, 1.2 Hz, 1H; H-14b),
3.95 (d, J=9.8 Hz, 1H; H-12b), 2.97–2.92 (m, 1H; H-6a), 2.82–2.75
(m, 1H; H-7a), 2.57–2.50 (m, 2H; H-6b and H-7b), 2.13–2.06 (m, 2H;
H-3a and H-1a), 1.91–1.84 (m, 1H; H-2a), 1.77–1.65 ppm (m, 3H; H-
1b, H-2b and H-3b); 13C NMR (125 MHz, CDCl3): d=148.3 (Cq, CAr),
136.9 (Cq, CAr), 136.3 (Cq, CAr), 135.7 (CH, C13), 128.4 (CH, CAr), 127.7
(Cq, CAr), 126.9 (CH, 2ꢂCAr), 126.8 (CH, 2ꢂCAr), 121.4 (CH, CAr), 119.6
(CH, CAr), 119.2 (CH2, C14), 118.3 (CH, CAr), 110.8 (CH, CAr), 109.2 (Cq,
CAr), 66.8 (Cq, C4), 54.7 (CH, C12b), 45.9 (CH2, C6), 38.5 (CH2, C1),
31.9 (CH2, C3), 22.5 (CH2, C7), 21.4 ppm (CH2, C2); HRMS (ESI): m/z
calcd for C23H25N2 329.2018 [M+H]+; found 329.2012.
Acknowledgements
(S)-3-Phenyl-2,5,7,8,13,13b-hexahydro-1H-azepino[1’,2’:1,2]pyri-
do[3,4-b]indole (17g): Prepared according to the general proce-
dure using 2q (37 mg, 0.104 mmol), Pd(PPh3)4 (6 mg, 0.055 mmol),
and DMBA 11 (49 mg, 0.312 mmol) in CH2Cl2 (1.0 mL). Purification
on silica gel (EtOAc/heptane, 50:50) afforded 17g. Yield: 25 mg
(0.079 mmol, 76%); yellow powder; Rf =0.26 (EtOAc/heptane,
50:50); [a]2D5 =ꢀ92.7 (c 1.00, CHCl3); IR (neat): n˜ =2922, 2849, 1483,
V.G. thanks the ICSN for financial support. The authors warmly
thank Dr. Angela Marinetti (ICSN) for her support and Lei Yang
(ICSN) for his contribution at the very beginning of the project.
1448, 1340, 1237, 1129, 1076, 1038, 909, 815, 742 cmꢀ1 1H NMR
;
Keywords: alkaloids · allenes · enantioselectivity · nitrogen
heterocycles · palladium
(300 MHz, CDCl3): d=7.73 (s, 1H; H-13), 7.48 (d, J=7.5 Hz, 1H;
ArH), 7.35–7.21 (m, 6H; 6ꢂArH), 7.16–7.06 (m, 2H; 2ꢂArH), 6.04
(td, J=5.7, 1.1 Hz, 1H; H-4), 4.22 (dd, J=10.4, 4.0 Hz, 1H; H-13b),
3.65 (dd, J=15.6, 5.1 Hz, 1H; H-5a), 3.52 (dd, J=16.0, 6.0 Hz, 1H;
H-5b), 3.27–3.19 (m, 1H; H-7a), 3.04–2.88 (m, 3H; H-7b, H-2a and
H-8a), 2.85–2.68 (m, 2H; H-2b and H-8b), 2.27–2.19 (m, 1H; H-1a),
2.06–1.94 ppm (m, 1H; H-1b); 13C NMR (75 MHz, CDCl3): d=144.0
(Cq, C3), 136.3 (Cq, CAr), 135.9 (Cq, CAr), 133.8 (Cq, CAr), 128.6 (CH, 2ꢂ
Rahman, A. Basha, Indole Alkaloids, Harwood Academic Publishers,
Reading, UK, 1999; d) M. J. Fisher, R. T. Backer, S. Husain, H. M. Hsiung,
J. T. Mullaney, T. P. O’Brian, P. L. Ornstein, R. R. Rothhaar, J. M. Zgombick,
Chem. Eur. J. 2015, 21, 1 – 11
9
ꢁ 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
&
&
These are not the final page numbers! ÞÞ